Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation

NCT07221760 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Dentatorubral-Pallidoluysian Atrophy

Interventions

DRUG: nL-ATN1-001

Sponsor

n-Lorem Foundation

Collaborators

[object Object]